Evidence mapPaperPMID 41708803Full record

ArticleScientific reports2026

Identification of core cytotoxic T lymphocyte-related subtypes, establishment of a prognostic model, and analysis tumor microenvironment infiltration in HNSC.

Wanjin Jiang, Qi Liu, Huiling Chu, Yiguo Dai, Yao Li, Cheng Wu, Na Zuo, Fuqin Sun, Xinyue Hu, Ningning Wei and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Wanjin Jiang *Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Qi Liu *Department of Otorhinolaryngology Head and Neck Surgery, Wuhu Hospital, East China Normal University,(The Second People's Hospital of Wuhu), Wuhu, 241000, China.
Huiling Chu *Department of Otorhinolaryngology Head and Neck Surgery, Xuancheng City Central Hospital, Xuancheng, 242000, China.
Yiguo DaiDepartment of Otorhinolaryngology Head and Neck Surgery, Wuhu Hospital, East China Normal University,(The Second People's Hospital of Wuhu), Wuhu, 241000, China.
Yao LiDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Cheng WuDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Na ZuoDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Fuqin SunDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Xinyue HuDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Ningning WeiDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Zongyi FangDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China.
Hongting HuaDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Chaobing GaoDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Shaofeng LiuDepartment of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China. liusf_cn@163.com.
Qi YangDepartment of Gastroenterology, The First Affiliated Hospital of Wannan Medical College Yijishan Hospital, Wuhu, 241000, China. yangqi@wnmc.edu.cn.

Funding

Key Project of Wannan Medical College WK2024ZZD34Wannan Medical College Youth Project WK2024ZQNZ68Yijishan Hospital Talent Introduction Program YR202505
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSC) is a common and clinically diverse malignancy associated with poor outcomes. Recent evidence suggests that cytotoxic T lymphocyte evasion-related genes (CEGs) are pivotal regulators of tumor immune escape, yet their overall prognostic significance and influence on the tumor microenvironment (TME) in HNSC remain poorly defined. Here, a systematic analysis of 31 CEGs was conducted across TCGA and GEO HNSC datasets to identify molecular subtypes via consensus clustering. A risk score based on this signature was developed, validated in external cohorts, and integrated with clinical data into a nomogram. Associations between the risk score and TME features, immune checkpoints, somatic mutations, cancer stemness indices, and drug sensitivity were comprehensively assessed. The identified molecular subtypes exhibited markedly different immune infiltration patterns and survival outcomes. The developed model enabled effective patient stratification into high- and low-risk groups that differed significantly in overall survival. High-risk patients displayed upregulated immune checkpoint expression and heightened sensitivity to several chemotherapeutic agents. Knockdown of SERPINE1 in HNSC cell lines led to marked inhibition of both proliferation and colony formation. The findings demonstrate the critical involvement of CEGs in HNSC progression and immune modulation, and proposes a novel three-gene signature as a robust prognostic biomarker and potential guide for individualized therapy.

Indexed as

Head and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckT-Lymphocytes, CytotoxicTumor MicroenvironmentBiomarkers, TumorCell Line, TumorGene Expression Regulation, NeoplasticHumansPlasminogen Activator Inhibitor 1PrognosisBiomarkers, TumorPlasminogen Activator Inhibitor 1SERPINE1 protein, humanHead and neck squamous cell carcinomaPrognostic modelSERPINE1Tumor microenvironment

Identifiers

PMID41708803
PMCPMC13013816

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.